Ann: Letter to Optionholders, page-90

Hi Pledge,

Next time you open your mouth or should I say type, it would be in your best interest to do a little research.

During Cynata phase 1 trial, in GVHD, achieved the same result's, as it would of in a phase 3 trial.



So what caught my attention, was the result's in the above presentation, for GVHD where so fantastic and it meet all ENDPOINT'S.
Especially the the 60% overall survival rate, at 2 year's after receiving treatment.

So the part which I and also know, that many C.Y.P. investor's are proud of is this sentence.
Excellent safety results facilitate Cynata progressing directly to phase 2 clinical trials in multiple other indications.

So know it lead's to my next point were, I made this statement, in 1 of my other post yesterday.
(We where allowed to bypass Phase 1 trial's and go, straight to Phase 2 and also go to Phase 3 trial's).



As we all can see above, our next and up coming trial's, state's clearly, that for each trial's, at what Phase duration our trial's will commence.

I can clearly see multiply Phase 2 and a Phase 3 trial, been mentioned.

The Time and Money saved, from the bypassing Phase 1 trial's is some 30 million dollar's for each Phase cycle and the Time fact of 3 year's each saved. Not to forget the dilution to it share holder's.

http://files.cynata.com/640/201211InvestorPresentation.pdf

My only advice I give to all investor's, is that if 1 person fail's, to do proper research in the company that they wish to purchase share's in, then they must take, all responsibilities, if that company doesn't deliver the out come's required.

IMHO.

Regard's

Rossi70